Journal ArticleContinence (Amsterdam, Netherlands) · December 2024
AimDiabetic bladder dysfunction (DBD) is the most common diabetic complication. Patients present with overactive symptoms, underactive symptoms, or both. While strict glucose control may be expected to reverse DBD, prior studies have not been supp ...
Full textCite
Journal ArticleNeurourol Urodyn · November 2024
PURPOSE: Diabetic bladder dysfunction (DBD) is the most common diabetic complication. Logically, regulation of blood glucose should reverse dysfunction, but the Epidemiology of Diabetes Interventions and Complications study found strict control ineffective ...
Full textLink to itemCite
Journal ArticleBMC Urol · June 21, 2024
BACKGROUND: One of the most common, but least studied, diabetic complication is diabetic bladder dysfunction. Current therapies include glucose control and symptom-based interventions. However, efficacy of these therapies is mixed and often have undesirabl ...
Full textLink to itemCite
Journal ArticleInt Urol Nephrol · May 2024
PURPOSE: To determine the contributions of different durations of hypoxia to NLRP3 inflammasome activation in urothelial cells and how ischemic changes in bladder tissues is an important chemical que that leads to pathological changes seen in BOO. METHODS: ...
Full textLink to itemCite
Journal ArticleFront Biosci (Landmark Ed) · April 18, 2024
BACKGROUND: Diabetic bladder dysfunction (DBD) is driven in part by inflammation which dysregulates prostaglandin release in the bladder. Precise inflammatory mechanisms responsible for such dysregulation have been elusive. Since prostaglandins impact blad ...
Full textLink to itemCite
Journal ArticleSci Immunol · March 2024
Urinary tract infections (UTIs) account for almost 25% of infections in women. Many are recurrent (rUTI), with patients frequently experiencing chronic pelvic pain and urinary frequency despite clearance of bacteriuria after antibiotics. To elucidate the b ...
Full textLink to itemCite
Journal ArticleAm J Physiol Renal Physiol · July 1, 2023
Diabetic bladder dysfunction (DBD) is a prevalent diabetic complication that is recalcitrant to glucose control. Using the Akita mouse model (type 1) bred to be NLR family pyrin domain containing 3 (NLRP3)+/+ or NLRP3-/-, we have previously found that fema ...
Full textLink to itemCite
Journal ArticleInt J Mol Sci · February 1, 2023
Anecdotal evidence has long suggested that patients with lower urinary tract symptoms (LUTS) develop mood disorders, such as depression and anxiety, at a higher rate than the general population and recent prospective studies have confirmed this link. Break ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Physiol Renal Physiol · December 1, 2022
Approximately half of the patients with diabetes develop diabetic bladder dysfunction (DBD). The initiation and progression of DBD is largely attributed to inflammation due to dysregulated glucose and the production of toxic metabolites that activate the N ...
Full textLink to itemCite
Journal ArticleLife Sci · June 15, 2022
AIMS: Diabetic bladder dysfunction (DBD) is a prevalent diabetic complication thought to progress from overactive (OAB) to underactive (UAB) bladder. Previously we found OAB at 15 weeks in the Akita mouse, a genetic model of Type 1 diabetes. The first aim ...
Full textLink to itemCite
Journal ArticleExp Biol Med (Maywood) · April 2022
Inflammation is a central process in most benign bladder disorders, and its control is a delicate balance between initiating factors and resolving factors. While recent discoveries have shown a central role for the NLRP3 inflammasome in initiation, the res ...
Full textLink to itemCite
Journal ArticleFront Physiol · 2022
Diabetes is a rapidly expanding epidemic projected to affect as many as 1 in 3 Americans by 2050. This disease is characterized by devastating complications brought about high glucose and metabolic derangement. The most common of these complications is dia ...
Full textOpen AccessLink to itemCite
Journal ArticleInt Urol Nephrol · October 2021
PURPOSE: To determine the unique contributions from elevated voiding and storage pressures in the development of fibrosis and the epithelial-to-mesenchymal transition (EMT) in urothelial cells, and how progressive BOO pressure cycling is an important mecha ...
Full textLink to itemCite
Journal ArticleAm J Physiol Renal Physiol · October 1, 2021
Bladder outlet obstruction (BOO) is ultimately experienced by ≈90% of men, most commonly secondary to benign prostatic hyperplasia. Inflammation is a critical driver of BOO pathology in the bladder and can be divided into two critical steps: initiation and ...
Full textLink to itemCite
Journal ArticleNeurourol Urodyn · August 2020
AIMS: Reports link urinary dysfunction and mood disorders, such as depression, but a causative mechanism has never been postulated. Contemporary discoveries demonstrate a local inflammatory response in peripheral organs can trigger inflammation in the brai ...
Full textLink to itemCite
Journal ArticleNat Immunol · June 2020
Urinary tract infections (UTIs) typically evoke prompt and vigorous innate bladder immune responses, including extensive exfoliation of the epithelium. To explain the basis for the extraordinarily high recurrence rates of UTIs, we examined adaptive immune ...
Full textLink to itemCite
Journal ArticleAm J Physiol Renal Physiol · February 1, 2020
Recent breakthroughs demonstrate that peripheral diseases can trigger inflammation in the brain, causing psychosocial maladies, including depression. While few direct studies have been made, anecdotal reports associate urological disorders with mental dysf ...
Full textLink to itemCite
Journal ArticleAnn Biomed Eng · March 2019
Although the previous success of bladder tissue engineering demonstrated the feasibility of this technology, most polyester based scaffolds used in previous studies possess inadequate mechanical properties for organs that exhibit large deformation. The pre ...
Full textLink to itemCite
Journal ArticleDiabetes · February 2019
The NLRP3 inflammasome senses diabetic metabolites and initiates inflammation implicated in diabetic complications and neurodegeneration. No studies have investigated NLRP3 in diabetic bladder dysfunction (DBD), despite a high clinical prevalence. In vitro ...
Full textLink to itemCite
Journal ArticleAm J Physiol Renal Physiol · January 1, 2019
Bladder outlet obstruction (BOO) leads to progressive voiding dysfunction. Acutely, obstruction triggers inflammation that drives bladder dysfunction. Over time, inflammation leads to decreased bladder nerve density and increased fibrosis, responsible for ...
Full textLink to itemCite
Journal ArticleRes Rep Urol · 2019
OBJECTIVE: To investigate the in vitro activation of the NLRP3 inflammasome within bladder urothelium by stone-forming components. Further, to describe the contributions of reactive oxygen species (ROS) and thioredoxin-interacting protein (TXNIP), an impor ...
Full textOpen AccessLink to itemCite
Journal ArticleInt Urol Nephrol · September 2018
Partial bladder outlet obstruction (pBOO) is a prevalent urological condition commonly accompanied by increased intravesical pressure, inflammation, and fibrosis. Studies have demonstrated that pBOO results in increased NLRP3 inflammasome and caspase-1 act ...
Full textLink to itemCite
Journal ArticleNeurourol Urodyn · March 2018
AIMS: Denervation of the bladder is a detrimental consequence of bladder outlet obstruction (BOO). We have previously shown that, during BOO, inflammation triggered by the NLRP3 inflammasome in the urothelia mediates physiological bladder dysfunction and d ...
Full textOpen AccessLink to itemCite
Journal ArticleCurr Urol · February 2018
Irritative voiding symptoms (e.g. increased frequency and urgency) occur in many common pathologic conditions such as urinary tract infections and bladder outlet obstruction, and these conditions are well-established to have underlying inflammation that di ...
Full textOpen AccessLink to itemCite
Journal ArticleRes Rep Urol · 2018
PURPOSE: Diabetes is a grave and progressive condition characterized by debilitating complications. Diabetic bladder dysfunction (DBD) is a very common complication with no specific treatments currently available. Unlike other tissues affected by this dise ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Physiol Renal Physiol · September 1, 2017
Bladder outlet obstruction (BOO) triggers inflammation in the bladder through the NLRP3 inflammasome. BOO also activates fibrosis, which is largely responsible for the decompensation of the bladder in the chronic state. Because fibrosis can be driven by in ...
Full textOpen AccessLink to itemCite
Journal ArticleNeurourol Urodyn · April 2017
AIM: Central efferent and afferent neural pathways to and from the human urinary bladder are well-characterized, but the location and arborization of these nerves as they traverse the serosa, muscularis, and urothelial layers are not clearly defined. The p ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Physiol Renal Physiol · October 1, 2016
Inflammasomes are supramolecular structures that sense molecular patterns from pathogenic organisms or damaged cells and trigger an innate immune response, most commonly through production of the proinflammatory cytokines IL-1β and IL-18, but also through ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Urol · May 2016
PURPOSE: While bladder outlet obstruction is well established to elicit an inflammatory reaction in the bladder that leads to overactive bladder and fibrosis, little is known about the mechanism by which this is initiated. NLRs (NOD-like receptors) and the ...
Full textOpen AccessLink to itemCite
Journal ArticleInt Urol Nephrol · December 2015
PURPOSE: The urothelium is a frontline sensor of the lower urinary tract, sampling the bladder lumen and stimulating an immune response to infectious and noxious agents. Pattern recognition receptors (PRRs) recognize such agents and coordinate the innate r ...
Full textOpen AccessLink to itemCite
Journal ArticleNeurourol Urodyn · August 2015
AIMS: Bladder and renal dysfunction are secondary events of the inflammatory processes induced by spinal cord injury (SCI). S-Nitrosoglutathione (GSNO), an endogenous nitrosylating agent is pleiotropic and has anti-inflammatory property. Hence, GSNO amelio ...
Full textLink to itemCite
Journal ArticleBJU Int · April 2015
OBJECTIVES: To develop a urodynamic model incorporating external urethral sphincter (EUS) electromyography (EMG) in awake rats. MATERIALS AND METHODS: Bladder catheters and EUS EMG electrodes were implanted in female Sprague Dawley rats. Assessments were p ...
Full textLink to itemCite
Journal ArticleAm J Physiol Renal Physiol · February 1, 2014
Bladder inflammation (cystitis) underlies numerous bladder pathologies and is elicited by a plethora of agents such as urinary tract infections, bladder outlet obstruction, chemotherapies, and catheters. Pattern recognition receptors [Toll-like receptors ( ...
Full textLink to itemCite
Journal ArticleUrology · January 2013
OBJECTIVE: To assess the ability of daily oral simvastatin administration to reduce the negative urodynamic changes associated with cyclophosphamide (CP)-induced cystitis and to prevent bladder inflammation. Patients undergoing CP chemotherapy frequently d ...
Full textLink to itemCite
Journal ArticleOpen Med Chem J · 2013
Kappa-opioid agonists are particularly efficacious in the treatment of peripheral pain but suffer from central nervous system (CNS)-mediated effects that limit their development. One promising kappa-agonist is the peptidic compound CR665. Although not oral ...
Full textLink to itemCite
Journal ArticleFish Shellfish Immunol · August 2011
Dermo disease in the eastern oyster (Crassostrea virginica) is caused by an intracellular protistan parasite Perkinsus marinus. The progression and outcome of this disease is determined by a complex interplay between the host's immunity and parasite's esca ...
Full textLink to itemCite
Journal ArticleFish Shellfish Immunol · August 2010
Dermo disease caused by the obligatory intracellular protozoan Perkinsus marinus causes extensive oyster mortalities leading to tremendous losses in the oyster industry and damage to estuarine ecosystems. To better understand the mechanisms of the parasite ...
Full textLink to itemCite
Journal ArticleJ Med Chem · June 24, 2010
The neurotensin hexapapetide fragment NT(8-13) is a potent analgesic when administered directly to the central nervous system but does not cross the blood-brain barrier. A total of 43 novel derivatives of NT(8-13) were evaluated, with one, ABS212 (1), bein ...
Full textLink to itemCite
Chapter · January 1, 2009
In this review, we will discuss how proteinaceous water channels, termed aquaporins (AQPs), regulate water fluxes across plasma membranes within various physiological and pathophysiological contexts. Particular emphasis has been assigned to changes in aqua ...
Full textCite
Journal ArticleNeuroimmunomodulation · 2008
OBJECTIVE: A decline in the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) may enhance cytokine release in Alzheimer's disease (AD) resulting in neuroinflammation. We investigated the GABA-mediated suppression of the synergistic release of inte ...
Full textLink to itemCite
Journal ArticleCancer Lett · May 18, 2007
Cells undergoing apoptosis are characterized by decreased cell size due to changes in intracellular ion concentration and rapid, aquaporin (AQP)-dependent water movement out of the cell, events required for the activation of pro-apoptotic enzymes. The curr ...
Full textLink to itemCite
Journal ArticleBiol Cell · January 2006
BACKGROUND INFORMATION: During apoptosis, the first morphological change is a distinct cell shrinkage known as the AVD (apoptotic volume decrease). This event is driven by a loss of intracellular K(+), which creates an osmotic gradient, drawing water out o ...
Full textLink to itemCite
Journal ArticleJ Exp Biol · September 2004
Exposure to environmentally prevalent heavy metals such as cadmium can have detrimental effects on a variety of commercially and ecologically important species such as oysters. Since Cd(2+) is known to induce apoptosis in immune cells of vertebrates, we ha ...
Full textLink to itemCite
Journal ArticleAm J Physiol Cell Physiol · April 2004
Apoptosis is characterized by a conserved series of morphological events beginning with the apoptotic volume decrease (AVD). This study investigated a role for aquaporins (AQPs) during the AVD. Inhibition of AQPs blocked the AVD in ovarian granulosa cells ...
Full textLink to itemCite
Journal ArticleBiology of reproduction · November 2003
Estrogen stimulates water imbibition in the uterine endometrium. This water then crosses the epithelial cells into the lumen, leading to a decrease in viscosity of uterine luminal fluid. To gain insight into the mechanisms underlying this estrogen-stimulat ...
Full textCite
Journal ArticleJ Interferon Cytokine Res · October 2002
A growing body of evidence has shown that bacterially challenged bone-forming osteoblasts are a significant source of an array of cytokines and chemokines that can support immune responses during bone disease. In the present study, Staphylococcus aureus an ...
Full textLink to itemCite
Journal ArticleEndocrinology · August 2002
Ovarian folliculogenesis is characterized, in part, by the formation and expansion of the fluid-filled antrum. Development of this cavity requires water influx, which may occur by transcellular or pericellular transport mechanisms. To assess the contributi ...
Full textLink to itemCite
Journal ArticleBiol Reprod · June 2001
More than 99% of ovarian follicles are lost by a degenerative process known as atresia, a phenomenon characterized by apoptosis of granulosa cells. Uniquely, dying granulosa cells also greatly increase their progesterone biosynthesis while reducing estroge ...
Full textLink to itemCite
Journal ArticleBiol Reprod · November 2000
Recent studies with thymocytes have suggested a critical role for intracellular potassium in the regulation of apoptosis. In this study, we examined the pathways of K(+) regulation during ovarian cell death. In initial studies, fluorographic analysis demon ...
Full textLink to itemCite
Journal ArticleEndocrinology · February 2000
In primary rat thymocytes, both glucocorticoids and the withdrawal of in vivo survival factors elicit apoptosis. In this study we wanted to determine whether distinct pathways leading to apoptosis are engaged by these two stimuli. To address this question, ...
Full textLink to itemCite
Book · 2000
One of the defining biochemical characteristics of apoptosis is the degradation of chromatin into regularly sized (oligonucleosomal and approximately 30- to 50-kb) fragments. Because destruction of the genome represents a clear commitment to death, conside ...
Full textLink to itemCite
Journal ArticleSteroids · September 1999
Apoptosis is a highly organized mechanism that allows specific cells to die in a controlled manner. Apoptosis can be induced by a variety of agents in a great number of cell types, but cell shrinkage and discrete chromatin cleavage remain common components ...
Full textLink to itemCite
ConferenceAdv Enzyme Regul · 1999
Apoptosis, or programmed cell death, is a fundamental biological process involved in many physiological and pathological phenomena. This process is predominantly catabolic in which cellular macromolecules are broken down by distinct enzymes to be later rec ...
Full textLink to itemCite
Journal ArticleCell Death Differ · December 1998
Chromatin degradation into oligonucleosomal and approximately 30-50 Kb fragments is a hallmark of apoptosis. Crude nuclear extract from apoptotic rat thymocytes is able to recapitulate both types of DNA fragmentation in an assay using HeLa cell nuclei as a ...
Full textLink to itemCite
Journal ArticleCell Death Differ · November 1998
Retinoids play an important role in the control of lymphocyte function and homeostasis in the thymus. In this study, we show that the induction of growth arrest and apoptosis in a variety of T-cell lymphoma cell lines, including Jurkat and Molt-4 cells, is ...
Full textLink to itemCite
ConferenceJ Steroid Biochem Mol Biol · April 1998
Glucocorticoids are well known to stimulate apoptosis in immature thymocytes. Apoptosis in this and other cells is characterized by cell shrinkage, DNA fragmentation and activation of a class of proteases named caspases. We have utilized the flow cytometer ...
Full textLink to itemCite
Journal ArticleEndocrinology · April 1998
Cytokines such as interleukin-1 (IL-1) and IL-6 stimulate the hypothalamic-pituitary-adrenal (HPA) axis. In addition, these proteins affect pituitary cell proliferation in vitro. Thymosin fraction 5 (TF5) is a partially purified preparation of the bovine t ...
Full textLink to itemCite
Journal ArticleCell Death Differ · January 1998
To continue elucidation of the biochemical and molecular pathways involved in the induction of apoptosis in granulosa cells (GC) of ovarian follicles destined for atresia, we characterized the occurrence and protease modulation of high and low molecular we ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · December 19, 1997
Cell shrinkage is a major characteristic of apoptosis, but the mechanism and role of this process in cell death are poorly understood. The primary factor that controls volume regulation in all cells is ions, and thus we have examined the movement of ions a ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · November 28, 1997
Little is known about the mechanisms of suppression of apoptosis. We have addressed the novel possibility that the level of intracellular K+ regulates the apoptotic process by controlling the activity of death enzymes. We show that K+, at normal intracellu ...
Full textLink to itemCite
Journal ArticleAm J Physiol · April 1997
The Ca2+-ATPase inhibitors, thapsigargin and cyclopiazonic acid, depleted intracellular Ca2+ stores, induced large increases in intracellular Ca2+ concentration, and caused apoptosis in S49 cells. Removal of extracellular Ca2+ augmented apoptosis due to th ...
Full textLink to itemCite
Journal ArticleCell Death Differ · April 1997
Apoptosis is commonly associated with the catabolism of the genome in the dying cell. The chromatin degradation occurs in essentially two forms: (1) internucleosomal DNA cleavage to generate oligonucleosomal-length fragments (180-200 bp and multiples there ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · March 7, 1997
Previous work in our laboratory (Montague, J., Gaido, M., Frye, C., and Cidlowski, J. (1994) J. Biol. Chem. 269, 18877-18880) has shown that human recombinant cyclophilins A, B, and C have sequence homology with the apoptotic nuclease NUC18 and that denatu ...
Full textLink to itemCite
Journal ArticleFASEB Journal · December 1, 1996
Degradation of chromatin into oligonucleosomal and/or large =3050 Kb fragments during apoptosis can be recapitulated in vitro in isolated rat thymocyte nuclei (i.e. autodigestion). We have used this model to assess the effects of K+ concentration on apopto ...
Cite
Journal ArticleRecent Prog Horm Res · 1996
Apoptosis is a form of programmed cell death that occurs under numerous developmental and physiological conditions that require the selective elimination of cells from tissues and organs without the production of an inflammatory response. The initiation of ...
Link to itemCite
Journal ArticleCell Death and Differentiation · December 1, 1994
Apoptosis is characterized by multiple morphological and biochemical changes. One biochemical change that has been primarily associated with apoptosis is the cleavage of chromatin in the internucleosomal regions. We have taken two independent approaches to ...
Cite
Journal ArticleJ Steroid Biochem Mol Biol · June 1994
Apoptosis, or programmed cell death, is a highly regulated physiological process by which individual cells die and are removed from a given population. This process, defined by both morphological and biochemical characteristics, has been extensively studie ...
Full textLink to itemCite
Journal ArticleAm J Reprod Immunol · 1994
PROBLEM: The localization and biological effects of atrial natriuretic peptide (ANP) are not limited to cardiac tissue but extend to a number of extra-atrial tissues and organs, including the ovary. The objective of the present study was to determine the e ...
Full textLink to itemCite
Journal ArticleEndocrinology · March 1992
Treatment of FSH-stimulated granulosa cells with increasing amounts of interleukin-6 (IL-6) caused a significant concentration-dependent suppression of progesterone biosynthesis. However, basal progesterone production in non-FSH-stimulated cells remained u ...
Full textLink to itemCite
Journal ArticleEndocrinology · November 1991
In the present study, we examined the possibility that granulosa cell death during ovarian follicular atresia occurs by apoptosis (programmed cell death). To investigate this possibility, atresia was induced in immature female rats by injecting 15 IU PMSG. ...
Full textLink to itemCite
Journal ArticleBiol Reprod · May 1991
We have previously demonstrated that a progestin-stimulatory factor(s) (PSF) is present in the supernate of concanavalin A-activated rat splenocytes. In the absence of FSH, PSF evokes dose-dependent increases in both progesterone and 20 alpha-hydroxypregn- ...
Full textLink to itemCite
Journal ArticleBiol Reprod · November 1990
Recent evidence indicates that factors produced by immune cells (cytokines) may play a role in ovarian function. To explore this possibility, we examined the effects of conditioned medium obtained from cultures of either unstimulated splenocytes (splenocyt ...
Full textLink to itemCite